Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian C Gaertner

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2025
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)Thomas Büttner, Milka Marinova, Florian C Gaertner, et al.
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2012
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrestMario Vallon, Christof Seidl, Birgit Blechert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP TrialPhilipp Krausewitz, Markus Essler, Florian C Gaertner, et al.
International Journal of Endocrinology|February 25, 2020
Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive CasesKarin Mayer, Selina Kiry, Anna Yordanova, et al.
Oncotarget|January 11, 2015
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myelomaKatharina Teiluf, Christof Seidl, Birgit Blechert, et al.
Medicine|September 24, 2021
Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomesRobert Mahn, Farsaneh Sadeghlar, Alexandra Bartels, et al.
Annals of Neurology|August 21, 2024
Higher Validity, Lower Radiation: A New Ictal Single-Photon Emission Computed Tomography FrameworkFelix Bitzer, Lennart Walger, Tobias Bauer, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid StatusShumei Li, Marcel Daamen, Lukas Scheef, et al.
Journal of Alzheimer'S Disease : JAD|August 28, 2023
Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive DeclineMarcel Daamen, Lukas Scheef, Shumei Li, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2025
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)Thomas Büttner, Milka Marinova, Florian C Gaertner, et al.
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2012
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrestMario Vallon, Christof Seidl, Birgit Blechert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP TrialPhilipp Krausewitz, Markus Essler, Florian C Gaertner, et al.
International Journal of Endocrinology|February 25, 2020
Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive CasesKarin Mayer, Selina Kiry, Anna Yordanova, et al.
Oncotarget|January 11, 2015
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myelomaKatharina Teiluf, Christof Seidl, Birgit Blechert, et al.
Medicine|September 24, 2021
Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomesRobert Mahn, Farsaneh Sadeghlar, Alexandra Bartels, et al.
Annals of Neurology|August 21, 2024
Higher Validity, Lower Radiation: A New Ictal Single-Photon Emission Computed Tomography FrameworkFelix Bitzer, Lennart Walger, Tobias Bauer, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid StatusShumei Li, Marcel Daamen, Lukas Scheef, et al.
Journal of Alzheimer'S Disease : JAD|August 28, 2023
Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive DeclineMarcel Daamen, Lukas Scheef, Shumei Li, et al.
Pageof 6